A large randomised placebo controlled trial among trauma patients with, or at risk of, significant haemorrhage, of the effects of antifibrinolytic treatment on death and transfusion requirement ISRCTN86750102

THE USE OF TRANEXAMIC ACID
Español	Portugûes	/ Chinese	PyccKo	/ Japanese

LISTEN	WATCH	READ	DOWNLOAD
Podcast	AN HOUR TO SAVE YOUR LIFE; In March 2014 the BBC aired a new programme exploring the life or death decisions facing medical professionals in the first critical hour of emergency care. The programme highlighted the current use of TXA in the UK trauma care, implemented as a direct result of the CRASH-2 collaboraton - something we can all feel proud for!	CRASH-2 Prognostic Model: Predicting early death in patients with traumatic bleeding: development and validation of prognostic model	PowerPoint presentation of the trial results
TXA song by BDCC choir	Clips from a BBC drama series Holby City	CRASH-2 trial results: Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial pdf-version	STOP the Bleeding Campaign
	ABC Television, Catalyst - Thin blood Featuring the CRASH-2 trial and our Australian investigators	CRASH-2 subgroup analysis: The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial; CRASH-2 Collaborators
	Ian Roberts presenting to the Massive Transfusion Consensus Conference in Canada in June 2011	Effect of consent rituals on mortality in emergency care research Ian Roberts, David Prieto-Merino, Haleema Shakur, Iain Chalmers, Jon Nicholl
	Comments from the collaborators	Cost-Effectiveness Analysis of Administering Tranexamic Acid to Bleeding Trauma Patients Using Evidence from the CRASH-2 Trial. Carla Guerriero, John Cairns, Pablo Perel, Haleema Shakur, Ian Roberts
	The promise of tranexamic acid, Dr Jerold H Levy, Emory University School of Medicine	Wikipedia
	Interview of Utako Okamoto, the inventor of tranexamic acid	Cochrane Injuries Group
		Implementation of the CRASH-2 results into clinical practice University of Leicester, Department of Cardiovascular Sciences FAQs
		BMC Emergency Medicine Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial

Last updated 7 May 2014